Dr. Gerald Diaz @GeraldMD
48.7M 14.2K 7.5K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
16 results
management hivaids infections idsa hypertensive mycobacterium 2016 aace antihypertensives aviumcomplex bcvi bloodpressure blunt candida candidiasis capsulatum cerebrovascular chagas cmv comparison
Oral anti-hypertensives with relative fast onset of action (Hypertensive Emergency) The key concern with oral antihypertensive agents
(Hypertensive Emergency ... of medication to ... #Hypertensive #Emergency ... #Management #Pharmacology ... #Table #BloodPressure
Medications Used in Hypertensive Emergencies Vasodilators: Hydralazine, Nitroglycerin, Sodium nitroprusside Calcium Channel Blockers: Clevidipine, Nicardipine ß-Blockers: Esmolol, Labetalol,
Medications Used ... #Hypertensive #Emergency ... #Management #Treatment ... #Pharmacology # ... Table
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity Mechanism of Action,
Table of Weight-Loss ... Medications approved ... the long-term treatment ... Mechanism of Action, Dose ... WeightLoss #AACE #2016 #Pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS Preventing Clinical Disease Indication: Individuals
be considered (doses ... Disease Note: Treatment ... PO in 2 divided doses ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS Indications for Initiating Primary Prophylaxis: •
Recommendations for Preventing ... Encephalitis in HIV-AIDS Indications ... Encephalitis #IDSA #Prevention ... #Treatment #opportunistic ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... mucosal #IDSA #Prevention ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS Treating Visceral Leishmaniasis - Preferred Therapy: •
Achieve a total dose ... Leishmaniasis #Prevention ... #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
Blunt cerebrovascular injury (BCVI) Blunt cerebrovascular injury (BCVI) can have severe neurologic sequelae. Early diagnosis is
diagnosis and treatment ... revascularization does ... In addition to preventing ... diagnosis #Imaging #Indications ... #emergency #Neurology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS Preventing CMV Disease: • CMV end-organ disease is best
Infections in HIV-AIDS Preventing ... ., concomitant medications ... injection) for 1–4 doses ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS Pre-Exposure Prevention of VZV
Recommendations for Preventing ... Primary Infection Indications ... (Varivax™), 2 doses ... #opportunistic ... infections #HIVAIDS #pharmacology
empty